2
Views
1
CrossRef citations to date
0
Altmetric
Original Article

Effects of VIP and PHM in Human Intracervical Arteries

, , , &
Pages 699-701 | Received 20 Jul 1987, Accepted 21 Jul 1988, Published online: 03 Aug 2009
 

Abstract

The relaxing effects of vasoactive intestinal polypeptide (VIP) and peptide histidine methionine (PHM) on human intracervical arteries were studied. Cervical tissue specimens were excised after hysterectomy at various phases of the menstrual cycle (n = 12) and small intracervical arteries were dissected free by microtechnique. Ring preparations of the vessels were prepared and mounted in organ baths, and isometric circular tension was recorded. None of the compounds showed any effects in unstimulated cervical arterial preparations. In vessels precontracted by noradrenalin 10−5 M, VIP lo−8 -10 −6 M and PHM 10−8 -10 −6 M induced similar, concentration-dependent relaxation with a maximum effect of 73.2±12.7% relaxation for VIP 10−6 M and 79.6±11.8% for PHM 10−6 M, as compared to 10.7±3.1% decrease in tension for control preparations treated with solvent (mean ± SE, n = 6). Simultaneous addition of VIP 5 × 10−7 M and PHM 5x10−7 M produced additive effects. Pretreatment with indometacin 10−6 M, atropine 10−6 M or propranolol 10−6 M did not significantly influence these responses. Both peptides might be involved in regulation of blood flow in the human cervix.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.